Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$79,000,000.00
Jan 9, 2026
For-profit organization
820313
820313
This project will commercialize bioprinted tissue therapeutics, expand AI-enabled bioprinting and cell engineering capabilities, and establish a commercial-scale Current Good Manufacturing Practice biomanufacturing facility with end-to-end automation. The project’s work phase is scheduled to end on March 31, 2031.
$49,000,000.00
Oct 4, 2024
For-profit organization
Project Podium: Establish a world-leading biomanufacturing facility & capabilities to advance and produce bioprinted tissue therapeutics in Canada
820057
Project Podium: Establish a world-leading biomanufacturing facility & capabilities to advance and produce bioprinted tissue therapeutics in Canada
$5,991.00
Oct 21, 2022
For-profit organization
CIIP PDA – Aspect Biosystems Ltd – 2022-23
7444817 P012263001
The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
$841,683.00
Sep 1, 2022
For-profit organization
Improvements to bioprinted pancreatic and liver tissues for clinical applications
997886
This project will support the firm to achieve key development and regulatory milestones for their bioprinted pancreatic tissue therapeutic for Type 1 Diabetes to advance to final IND-enabling studies, and to demonstrate their 3D bioprinting technology is a biomanufacturing platform by showing efficacy of bioprinted liver tissues in multiple liver diseases.
$3,485,869.00
Jan 11, 2022
For-profit organization
000021022
000021022
Increase sales of bioprinter technology services through improved business processes
$3,677,430.00
Jan 11, 2022
For-profit organization
000021022
000021022
Increase sales of bioprinter technology services through improved business processes
$33,000.00
Apr 1, 2021
For-profit organization
Aspect Biosystems Ltd.-2021-2022-972731
972731
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
$1,000,000.00
Jan 29, 2021
For-profit organization
000019683
000019683
Support Aspect Biosystems Ltd. to continue operations during the COVID-19 pandemic
$74,925.00
Jun 19, 2020
For-profit organization
Aspect Biosystems Business Development in Germany, Northeast USA and Midwest USA
954463
The proposed CanExport project addresses Aspect Biosystems’ international growth strategy of our microfluidic 3D bioprinting technology through market awareness and partnerships in targeted regions of the United States and Europe.
$581,851.00
Oct 28, 2019
For-profit organization
CIIP Korea Project 3D Printing Therapy
938664
CIIP Korea project 3D Printing Therapy will integrate unique 3D bioprinting technology from Aspect Biosystems Ltd. (Canada) with pluripotent stem cell technology from NEXEL Co., Ltd.